Phase Bioscience, Inc. (PhaseBio) is a biotechnology firm with a proprietary platform offering new solutions to the purification and delivery of protein-based and small molecule therapeutics. The company’s technology is based on recombinant elastin-like peptides (ELPs) which allows for biological drugs to be purified simply by changing temperature or salinity rather than by using expensive chromatography.